Free Trial

Synthomer (LON:SYNT) Stock Crosses Below Two Hundred Day Moving Average - What's Next?

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc's stock price dropped below its 200-day moving average of GBX 86.17, trading as low as GBX 59.40 during the recent session.
  • Analyst ratings reflect a consensus of "Hold" with price targets ranging from GBX 80 to GBX 140, indicating mixed outlooks on the company's performance.
  • Insider trading activity includes significant purchases, with insiders acquiring a total of 104,229 shares valued at approximately £54,498 in the last quarter.
  • MarketBeat previews top five stocks to own in November.

Synthomer plc (LON:SYNT - Get Free Report)'s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 86.17 ($1.16) and traded as low as GBX 59.40 ($0.80). Synthomer shares last traded at GBX 59.40 ($0.80), with a volume of 2,763,542 shares.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Synthomer from GBX 140 to GBX 115 and set a "hold" rating on the stock in a research note on Wednesday, July 30th. Berenberg Bank decreased their price objective on shares of Synthomer from GBX 120 to GBX 80 and set a "hold" rating on the stock in a research note on Wednesday, August 6th. Jefferies Financial Group reaffirmed a "hold" rating and set a GBX 100 price objective on shares of Synthomer in a research note on Tuesday, August 5th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Synthomer from GBX 200 to GBX 120 and set a "neutral" rating on the stock in a research note on Friday, October 10th. Four research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of GBX 103.75.

Check Out Our Latest Research Report on Synthomer

Synthomer Trading Up 0.3%

The stock has a market capitalization of £97.10 million, a P/E ratio of -116.24, a PEG ratio of -0.17 and a beta of 1.79. The company has a debt-to-equity ratio of 78.27, a current ratio of 1.90 and a quick ratio of 0.97. The business's 50 day simple moving average is GBX 65.15 and its 200-day simple moving average is GBX 86.17.

Synthomer (LON:SYNT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported GBX (5.40) earnings per share (EPS) for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. As a group, analysts forecast that Synthomer plc will post 12.962963 EPS for the current year.

Insider Buying and Selling at Synthomer

In other Synthomer news, insider Jonathan Silver acquired 59,229 shares of the business's stock in a transaction on Wednesday, August 6th. The stock was purchased at an average price of GBX 65 per share, with a total value of £38,498.85. Also, insider Uwe Halder acquired 25,000 shares of the business's stock in a transaction on Thursday, August 7th. The stock was acquired at an average cost of GBX 64 per share, with a total value of £16,000. Insiders acquired 104,229 shares of company stock valued at $6,729,885 in the last quarter. Company insiders own 4.99% of the company's stock.

Synthomer Company Profile

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.